Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).

被引：0
|
作者：
Saven, A
Burian, C
Kosty, M
Mason, J
Douer, D
机构：
[1] Ida M & Cecil H Green Canc Ctr, Div Hematol Oncol, Scripps Clin, La Jolla, CA USA
[2] Univ So Calif, Div Hematol, Norris Canc Ctr, Los Angeles, CA USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4459
引用
收藏
页码：279B / 279B
页数：1
相关论文
共 50 条
  • [41] Proposal of a scoring system for responsiveness to interferon-alpha at diagnosis in chronic myelogenous leukemia.
    Dascalescu, CM
    Chomel, JC
    Bouilly, I
    Chauvet, M
    Sotto, MF
    Guilhot, J
    Rivet, J
    Sotto, JJ
    Kitzis, A
    Guilhot, F
    [J]. BLOOD, 1997, 90 (10) : 3988 - 3988
  • [42] PROLONGED SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA AFTER CYTOGENETIC RESPONSE TO INTERFERON-ALPHA THERAPY
    KANTARJIAN, HM
    SMITH, TL
    OBRIEN, S
    BERAN, M
    PIERCE, S
    TALPAZ, M
    ROBERTSON, L
    KOLLER, C
    ESTEY, E
    KEATING, MJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (04) : 254 - 261
  • [43] A potential mechanism for the resistance of interferon-alpha treatment in chronic myelogenous leukemia patients.
    Henderson, Y
    Deisseroth, AB
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A232 - A232
  • [44] Follow-up of nonclonal hematopoetic progenitor cells in the peripheral blood of interferon-alpha treated patients with chronic myelogenous leukemia (CML).
    Sick, C
    Schultheis, B
    Pasternak, G
    Heissig, B
    Hehlmann, R
    [J]. BLOOD, 1997, 90 (10) : 4016 - 4016
  • [45] Adverse reactions of interferon-alpha (IFN-alpha) in patients with chronic myeloid leukemia.
    Hasford, J
    Puosi, F
    Ansari, H
    Hochhaus, A
    Hehlmann, R
    [J]. BLOOD, 1997, 90 (10) : 3992 - 3992
  • [46] The interferon-alpha revival in CML
    Talpaz, Moshe
    Mercer, Jessica
    Hehlmann, Ruediger
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 : S195 - S207
  • [47] INTERFERON-ALPHA IN THE THERAPY OF CML
    TALPAZ, M
    KANTARJIAN, H
    KURZROCK, R
    GUTTERMAN, JU
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 : 38 - 41
  • [48] COMBINED MODALITY THERAPY WITH INTENSIVE CHEMOTHERAPY (DOAP) FOLLOWED BY ALPHA-INTERFERON (IFN-A) MAINTENANCE IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, HM
    TALPAZ, M
    KEATING, MJ
    WALTERS, RS
    MCCREDIE, KB
    FREIREICH, EJ
    GUTTERMAN, JU
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 210 - 210
  • [49] Adjuvant Treatment with Alpha Interferon (IFN) for Patients at High Risk for Relapse after Allogeneic Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
    Bezerra, Evandro Dantas
    Radich, Jerald
    Flowers, Mary E.
    Chielins, Debbie
    Higano, Celestia
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S238 - S238
  • [50] The interferon-alpha revival in CML
    Moshe Talpaz
    Jessica Mercer
    Rüdiger Hehlmann
    [J]. Annals of Hematology, 2015, 94 : 195 - 207
12345